Information Provided By:
Fly News Breaks for February 25, 2020
Feb 25, 2020 | 07:45 EDT
Credit Suisse analyst Erin Wilson Wright raised her price target for Medpace to $99 from $91 following quarterly results and to reflect a higher view and greater conviction in its growth prospects in a strong fundamental backdrop. The analyst reiterates an Outperform rating on the stock, adding that momentum in the shares may continue on the latest Q4 and 2020 operational guidance upside.
News For MEDP From the Last 2 Days
There are no results for your query MEDP